Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
68 participants
OBSERVATIONAL
2022-06-21
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multigen Plus H Study and AMF TT Cones
NCT04884542
Evaluation of a New Bi-Condylar Total Knee Prosthesis (TKP) With All-Ceramic Friction (The Forgotten Knee)
NCT06592248
A Multi-Center Study Assessing the Safety and Efficacy of the LEGION Medial Stabilized (MS) Insert in Patients Undergoing a Total Knee Arthroplasty (TKA)
NCT07199738
Medico-economic Interest of the Patient Matched Cutting Blocks (Ancillary) MyKnee ® LBS During the Poses of Complete Prosthesis of Knee GMK ®. Multicentric, Prospective, Controlled, Opened, Randomised Study About a Medical Device. (My Knee)
NCT01818401
Radiographic Migration Analysis of the ATTUNE Cementless CR Fixed-Bearing Total Knee Replacement
NCT06189872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The assignment of any subject involved in the study is determined preoperatively by the aetiology evaluated by the Investigator and falls within the current practice. The decision to use this specific prosthesis design is decided by the Investigators independently and clearly separated from the decision to include the subject in the study.
Baseline measurements (pre-operative clinical assessment and radiographic analysis at discharge) serves as internal control for the assessment of post-operative data.
The study will be carried out in 3 sites in Europe for a total number of 68 study subjects, in whom the decision to implant the Multigen Plus CCK system, alone or in combination with the AMF TT cones, has been taken prior to, and independently from, the decision to include the subject in the study.
The enrolment is competitive until the required recruitment target is met.
The expected number of visits for each study subject is 6, and includes:
* a pre-operative visit (before the subject receives the Multigen Plus CCK system alone or involving the AMF TT cones).
* the intra-operative visit (that is the same day of the surgery).
* the discharge visit (after the surgery according to the clinical practice).
* the following follow-up visits: at 3 months, 12 months, and 24 months after the surgery.
All eligible subjects who agree to participate in the study will be recruited and monitored throughout the duration of the study. For each visit and for each single study subject, radiographic and clinical data will be assessed up to the 24-month follow-up visit according to the standard of care of the site, when applicable. Also, Adverse Events and Serious Adverse Events will be collected and assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multigen Plus CCK
Multigen Plus CCK
Total Knee Arthroplasty
Multigen Plus CCK in combination with AMF TT cones
Multigen Plus CCK
Total Knee Arthroplasty
AMF TT cones
To fill a proximal tibia or distal femur defect
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multigen Plus CCK
Total Knee Arthroplasty
AMF TT cones
To fill a proximal tibia or distal femur defect
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years old.
* Given written informed consent approved by the reference Ethics Committee (EC).
* Subjects in whom a decision has already been made to perform a Total Knee Arthroplasty with Multigen Plus system as per Indication For Use. The decision to implant a Multigen Plus CCK system, alone or involving the AMF TT cones, must be taken prior to, and independently from, the decision to enrol the subject. This decision should be made in accordance with routine clinical practice at the study site concerned.
* Subjects able to comply with the Study Protocol.
Exclusion Criteria
* Subjects with any Multigen Plus system contraindication for use, or any AMF TT cones contraindication for use when used in combination with the Multigen Plus CCK, as reported in the current Instruction For Use.
* Any clinically significant pathology based on the medical history that the Investigator feels may affect the study evaluation.
* Female subjects who are pregnant, nursing, or planning a pregnancy.
* Previous knee replacement on the contralateral side within the last year and whose outcome is achieving an KSS \< 70 points.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Limacorporate S.p.a
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Senhora da Oliveira in Guimarães
Guimarães, , Portugal
Saints Cyril and Methodius Hospital
Bratislava, , Slovakia
Royal Devon and Exeter Hospital
Exeter, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K-24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.